Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Long Chuang

Showing results (211-220 of 456) with videos related to

Pageof 46
Sort By:
Oncotarget|March 20, 2018
Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis CMing-Lun Yeh, Ching-I Huang, Chung-Feng Huang, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 8, 2008
Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in TaiwanChung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2008
Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infectionsJee-Fu Huang, Chia-Yen Dai, Ya-Yun Lin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 23, 2008
Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis CChia-Yen Dai, Wan-Long Chuang, Li-Po Lee, et al.
The Kaohsiung Journal of Medical Sciences|July 4, 2007
Qualitative application of COBAS AMPLICOR HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0Ming-Yen Hsieh, Li-Po Lee, Nai-Jen Hou, et al.
Journal of Gastroenterology and Hepatology|May 10, 2024
Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver diseaseYi-Ting Chen, Tzu-I Chen, Szu-Ching Yin, et al.
Biomedicines|October 23, 2021
The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 ExpressionCiniso Sylvester Shabangu, Phumelele Yvonne Siphepho, Chia-Yang Li, et al.
Hepatology (Baltimore, Md.)|June 30, 2015
Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infectionJean-Michel Pawlotsky, Robert Flisiak, Shiv K Sarin, et al.
Plos One|August 9, 2019
Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patientsMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|September 15, 2012
Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese populationMeng-Hsuan Hsieh, Wen-Yi Lin, Hsu-Han Chien, et al.
Pageof 46

Showing results (211-220 of 456) with videos related to

Sort By:
Pageof 46
Oncotarget|March 20, 2018
Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis CMing-Lun Yeh, Ching-I Huang, Chung-Feng Huang, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 8, 2008
Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in TaiwanChung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2008
Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infectionsJee-Fu Huang, Chia-Yen Dai, Ya-Yun Lin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 23, 2008
Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis CChia-Yen Dai, Wan-Long Chuang, Li-Po Lee, et al.
The Kaohsiung Journal of Medical Sciences|July 4, 2007
Qualitative application of COBAS AMPLICOR HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0Ming-Yen Hsieh, Li-Po Lee, Nai-Jen Hou, et al.
Journal of Gastroenterology and Hepatology|May 10, 2024
Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver diseaseYi-Ting Chen, Tzu-I Chen, Szu-Ching Yin, et al.
Biomedicines|October 23, 2021
The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 ExpressionCiniso Sylvester Shabangu, Phumelele Yvonne Siphepho, Chia-Yang Li, et al.
Hepatology (Baltimore, Md.)|June 30, 2015
Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infectionJean-Michel Pawlotsky, Robert Flisiak, Shiv K Sarin, et al.
Plos One|August 9, 2019
Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patientsMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|September 15, 2012
Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese populationMeng-Hsuan Hsieh, Wen-Yi Lin, Hsu-Han Chien, et al.
Pageof 46